↓ Skip to main content

Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper
Published in
Orphanet Journal of Rare Diseases, February 2023
DOI 10.1186/s13023-023-02635-3
Pubmed ID
Authors

N. Zozaya, J. Villaseca, F. Abdalla, A. Ancochea, I. Málaga, M. Trapero-Bertran, N. Martín-Sobrino, O. Delgado, P. Ferré, A. Hidalgo-Vega

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 11%
Lecturer 1 6%
Other 1 6%
Student > Master 1 6%
Professor > Associate Professor 1 6%
Other 0 0%
Unknown 12 67%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 11%
Nursing and Health Professions 1 6%
Business, Management and Accounting 1 6%
Medicine and Dentistry 1 6%
Unknown 13 72%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2023.
All research outputs
#14,645,319
of 23,445,423 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,618
of 2,697 outputs
Outputs of similar age
#151,450
of 340,684 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#18
of 61 outputs
Altmetric has tracked 23,445,423 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,697 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.